Analyst's ConfidenceAnalyst reiterates a Buy rating and raises the price target to $390, seeing CRWD as a beneficiary of Generative AI, reflecting a strong vote of confidence in the company's growth trajectory.
Market Penetration25 of the 50 U.S. states have standardized on the company's platform at the enterprise level, showcasing widespread adoption and trust in the product.
Revenue GrowthThe company expects to recognize approximately 60% of the $4.6B RPO over the next 12 months, indicating strong future revenue potential.